These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2847818)
1. [Ceruloplasmin receptor on human erythrocytes]. Saenko EL; Basevich VV; Iaropolov AI Biokhimiia; 1988 Aug; 53(8):1310-5. PubMed ID: 2847818 [TBL] [Abstract][Full Text] [Related]
2. Studies on receptor interaction of ceruloplasmin with human red blood cells. Saenko EL; Yaropolov AI Biochem Int; 1990; 20(2):215-25. PubMed ID: 2156504 [TBL] [Abstract][Full Text] [Related]
3. [Characteristics of ceruloplasmin interaction with a specific receptor of human erythrocytes]. Saenko EL; Basevich VV; Iaropolov AI Biokhimiia; 1988 Feb; 53(2):317-21. PubMed ID: 2835996 [TBL] [Abstract][Full Text] [Related]
4. [Various properties of the ceruloplasmin receptor, isolated from human erythrocyte membranes]. Puchkova LV; Verbina IA; Denezhkina VV; Shavlovskiĭ MM; Gaĭtskoki VS; Neĭfakh SA Biokhimiia; 1990 Dec; 55(12):2182-9. PubMed ID: 1965784 [TBL] [Abstract][Full Text] [Related]
5. Reconstitution of the intercellular transfer pathway of the peptide moiety of ceruloplasmin in mammals. Puchkova LV; Sasina LK; Aleinikova TD; Zakharova ET; Gaitskhoki VS Biochemistry (Mosc); 1997 Jul; 62(7):697-703. PubMed ID: 9331961 [TBL] [Abstract][Full Text] [Related]
6. [Interaction of molecular forms of ceruloplasmin with specific membrane receptors from healthy persons and patients with hepatolenticular degeneration]. Puchkova LV; Verbina IA; Gaĭtskoki VS; Neĭfakh SA Biokhimiia; 1991 Dec; 56(12):2261-9. PubMed ID: 1666959 [TBL] [Abstract][Full Text] [Related]
7. Molecular forms of ceruloplasmin in hepatolenticular degeneration and their interaction with human erythrocyte ceruloplasmin receptor. Puchkova LV; Verbina IA; Denezhkina VV; Vakharlovskii VG; Voitsekhovskii BL; Gaitskhoki VS; Neifakh SA Biomed Sci; 1990; 1(5):460-6. PubMed ID: 1966785 [TBL] [Abstract][Full Text] [Related]
8. Partial purification of the rat erythrocyte ceruloplasmin receptor monitored by an electrophoresis mobility shift assay. Stern RV; Frieden E Anal Biochem; 1993 Jul; 212(1):221-8. PubMed ID: 8396362 [TBL] [Abstract][Full Text] [Related]
9. Identification of ceruloplasmin receptors on the surface of human blood monocytes, granulocytes, and lymphocytes. Kataoka M; Tavassoli M Exp Hematol; 1985 Sep; 13(8):806-10. PubMed ID: 2995102 [TBL] [Abstract][Full Text] [Related]
10. The protective effect of normal and pathological (Wilson disease) ceruloplasmins on human erythrocytes. Saenko EL; Skorobogat'ko OV; Yaropolov AI Biochem Int; 1990; 20(3):463-9. PubMed ID: 2161227 [TBL] [Abstract][Full Text] [Related]
11. Interrelation between structure and protective action of normal and pathological ceruloplasmins during copper-induced lysis of red blood cells. Saenko EL; Skorobogat'ko OV; Yaropolov AI Biochem Int; 1990 Nov; 22(4):749-57. PubMed ID: 1964048 [TBL] [Abstract][Full Text] [Related]
12. Protective action of blood ceruloplasmin obtained from normal individuals on red blood cells compared with that from patients with Wilson's disease. Saenko EL; Skorobogat'ko OV; Yaropolov AI Biomed Sci; 1990; 1(5):453-9. PubMed ID: 1966784 [TBL] [Abstract][Full Text] [Related]
13. Liver endothelium binds, transports, and desialates ceruloplasmin which is then recognized by galactosyl receptors of hepatocytes. Tavassoli M Trans Assoc Am Physicians; 1985; 98():370-7. PubMed ID: 3022446 [TBL] [Abstract][Full Text] [Related]
14. Study of intracellular localization and traffic of newly synthesized ceruloplasmin receptor in cultured human fibroblasts. Sasina LK; Puchkova LV; Gaitskhoki VS Biochemistry (Mosc); 1998 Oct; 63(10):1172-7. PubMed ID: 9864451 [TBL] [Abstract][Full Text] [Related]
15. Ceruloplasmin receptors of erythrocytes. Barnes G; Frieden E Biochem Biophys Res Commun; 1984 Nov; 125(1):157-62. PubMed ID: 6095836 [TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of ceruloplasmin receptors. Omoto E; Tavassoli M Trans Assoc Am Physicians; 1989; 102():170-5. PubMed ID: 2561640 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of experimentally induced enzymatic alterations on the erythrocyte membrane by use of alcian blue. Feuerstein H; Halbhuber KJ; Linss W Haematologia (Budap); 1993; 25(4):277-82. PubMed ID: 8157210 [TBL] [Abstract][Full Text] [Related]
18. Identification of human platelet membrane fibrinogen receptors by immunochemical techniques. Kornecki E; Tuszynski GP; Niewiarowski S Haematologia (Budap); 1984; 17(3):387-98. PubMed ID: 6100105 [TBL] [Abstract][Full Text] [Related]
19. [Protective effect of various forms of human ceruloplasmin in copper-induced erythrocyte lysis]. Saenko EL; Iaropolov AI Biokhimiia; 1991 Apr; 56(4):648-54. PubMed ID: 1655069 [TBL] [Abstract][Full Text] [Related]
20. [Interconnection between the structure and protective action of normal and pathological ceruloplasmin preparations in copper-induced erythrocyte lysis]. Saenko EL; Skorobogat'ko OV; Iaropolov AI Biokhimiia; 1991 May; 56(5):820-7. PubMed ID: 1747411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]